Not known Factual Statements About semaglutide Week 1-6 Bundle
The trial obtained both its Key endpoints, with semaglutide 2.4 mg demonstrating statistically sizeable and exceptional improvements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH when compared to placebo.oneSemaglutide comes in a powder sort a